Clinical supervision is an effective learning and development tool which nurses, and other healthcare professionals, can use to promote and maintain high standards of patient care. This Unit explains the concept behind clinical supervision and looks at the work carried out nationally to develop its use in practice. Clinical supervision has been shown to offer many benefits for the individual practitioner, the supervisor and the organisation and these are discussed in detail; as are the various methods and models which can be employed to implement clinical supervision. A knowledge of these models and the possible outcomes they can elicit for the individual is important, because it will allow the participants to tailor the process for their own special needs. Lastly, the essential element of evaluating the process is discussed. This is vital for supporting evidence-based practice in health care and providing positive outcomes for patient care.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Fluid structure Interaction analysis for rupture risk assessment in patients with middle cerebral artery aneurysms.
Sci Rep
January 2025
Department of Neurosurgery, Kepler University Hospital and Johannes Kepler University Linz, Wagner-Jauregg Weg 15, 4020 Linz and Altenbergerstrasse 69, Linz, 4040, Austria.
Accurate rupture risk assessment is essential for optimizing treatment decisions in patients with cerebral aneurysms. While computational fluid dynamics (CFD) has provided critical insights into aneurysmal hemodynamics, most analyses focus on blood flow patterns, neglecting the biomechanical properties of the aneurysm wall. To address this limitation, we applied Fluid-Structure Interaction (FSI) analysis, an integrative approach that simulates the dynamic interplay between hemodynamics and wall mechanics, offering a more comprehensive risk assessment.
View Article and Find Full Text PDFOral vancomycin induced flushing syndrome in a multiple myeloma patient: A case report and review of the literature.
Medicine (Baltimore)
November 2024
Department of Clinical Pharmacy, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Background: Patients with hematological malignancies are at high-risk of Clostridium difficile infection (CDI). Oral vancomycin is a first-line treatment for CDI. Vancomycin has been widely reported to induce flushing syndrome (also known as Red man syndrome), a well-known hypersensitivity reaction mostly occurs after intravenous administration.
View Article and Find Full Text PDFWeakly-supervised thyroid ultrasound segmentation: Leveraging multi-scale consistency, contextual features, and bounding box supervision for accurate target delineation.
Comput Biol Med
January 2025
Department of Artificial Intelligence, Faculty of Artificial Intelligence, Egyptian Russian University, 11829, Badr City, Egypt. Electronic address:
Weakly-supervised learning (WSL) methods have gained significant attention in medical image segmentation, but they often face challenges in accurately delineating boundaries due to overfitting to weak annotations such as bounding boxes. This issue is particularly pronounced in thyroid ultrasound images, where low contrast and noisy backgrounds hinder precise segmentation. In this paper, we propose a novel weakly-supervised segmentation framework that addresses these challenges.
View Article and Find Full Text PDFPatients' attitudes toward artificial intelligence (AI) in cancer care: A scoping review protocol.
PLoS One
January 2025
Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
Background: Artificial intelligence broadly refers to computer systems that simulate intelligent behaviour with minimal human intervention. Emphasizing patient-centered care, research has explored patients' perspectives on artificial intelligence in medical care, indicating general acceptance of the technology but also concerns about supervision. However, these views have not been systematically examined from the perspective of patients with cancer, whose opinions may differ given the distinct psychosocial toll of the disease.
View Article and Find Full Text PDFBuparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 Study.
Target Oncol
January 2025
Hematology-Oncology Service, Department of Medicine, Centre hospitalier de l'Université de Montréal (CHUM), 1000, rue Saint-Denis, Montreal, QC, Canada.
Background: BERIL-1 was a randomized phase 2 study that studied paclitaxel with either buparlisib, a pan-class I PIK3 inhibitor, or placebo in patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC). Considering the therapeutic paradigm shift with immune checkpoint inhibitors (ICIs) now approved in the first-line setting, we present an updated immunogenomic analysis of patients enrolled in BERIL-1, including patients with immune-infiltrated tumors.
Objective: The objective of this study was to identify biomarkers predictive of treatment efficacy in the context of the post-ICI therapeutic landscape.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!